Manufacturer record

Polestar Power Industries (Pharma Division): regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Polestar Power Industries (Pharma Division) (Himachal Pradesh) were declared Not of Standard Quality between February 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: TB250343C, Amoxycillin & Potassium Clavulanate Tablets IP (exp Feb 2027). Lucknow Lab (state lab) found it not of standard quality: Identification - Doesn't conforms to I.P. Listed in the July 2026 alert.

Records by type

4 records linked to Polestar Power Industries (Pharma Division) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2019 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2019
3
Products affected
Assay
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2019 · 22026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Amoxycillin & Potassium Clavulanate Tablets IP Batch TB250343CMfg Jun 2025 · Exp Feb 2027 Identification - Doesn't conforms to I.P.Identification Lucknow LabState lab Jul 2026
Amoxycillin and Potassium Clavulanate Tablets IP Batch TB250485KMfg Aug 2025 · Exp Jan 2027 The sample does not conform specification with respect to content of Amoxycillin and Clavunate Acid A,pxuco;;om 52.27%, Cavulanic Acid 19.24% of claim)Other BDCL, PatnaState lab May 2026
CefpodoximeProxeti l and Potassium Clavulanate Tablets (STOPDOX-CV TABLETS) Batch T180097FMfg Jun 2018 · Exp Nov 2019 Assay of Potassium Clavulanate Diluted calculated as Clavulanic AcidAssay RDTL ChandigarhCDSCO lab Mar 2019
Cefixime And Lactic Acid Bacillus Dispersible Tablets (EUROX-200 LB TABLETS) Batch T180064FMfg Apr 2018 · Exp Mar 2020 Assay of Lactic Acid BacillusAssay RDTL ChandigarhCDSCO lab Feb 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.